YPEL3 and nasopharyngeal carcinoma: YPEL3 has been proposed to act as a negative regulator of the WNT/ß-Catenin signaling pathway by preventing ß -Catenin nuclear translocation during metastasis of nasopharyngeal carcinoma cells [35].